|
[1]
|
曾国华, 等. 经皮肾镜碎石术[M]. 北京: 人民卫生出版, 2011: 226-227.
|
|
[2]
|
Rivera, M., et al. (2016) Pre- and Postoperative Predictors of Infection-Related Complications in Patients Undergoing Percutaneous Nephrolithotomy. Journal of Endourology, 30, 982-986. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Martin, G.S., et al. (2003) The Epidemiology of Sepsis in the United States from 1979 through 2000. The New England Journal of Medicine, 348, 1546-1554. [Google Scholar] [CrossRef]
|
|
[4]
|
Fleischmann, C., et al. (2016) Hospital Incidence and Mortality Rates of Sepsis. Deutsches Ärzteblatt International, 113, 159-166.
|
|
[5]
|
刘冰, 王国兴, 孙雪莲. 血清降钙素原和D-二聚体检测在急诊脓毒症患者病情及预后评估中的应用价值[J]. 临床和实验医学杂志, 2020, 19(3): 310-313.
|
|
[6]
|
Silcock, D.J., Corfield, A.R., Staines, H., et al. (2019) Superior Performance of National Early Warning Score Compared with Quick Sepsis-Related Organ Failure Assessment Score in Predicting Adverse Outcomes: A Retrospective Observational Study of Patients in the Prehospital Setting. European Journal of Emergency Medicine, 26, 433-439. [Google Scholar] [CrossRef]
|
|
[7]
|
Weibel, E.R. (2012) Fifty Years of Weibel-Palade Bodies: The Discovery and Early History of an Enigmatic Organelle of Endothelial Cells. Journal of Thrombosis and Haemostasis, 10, 979-984. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Brodska, H, et al. (2013) Significantly Higher Procalcitonin Levels Could Differentiate Gram-Negative Sepsis from Gram-Positive and Fungal Sepsis. Clinical and Experimental Medicine, 13, 165-167. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Leli, C., et al. (2015) Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections. Disease Markers, 2015, Article ID: 701480. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Bassetti, M., et al. (2019) Role of Procalcitonin in Predicting Etiology in Bacteremic Patients: Report from a Large Single-Center Experience. Journal of Infection and Public Health, 13, 40-45.
|
|
[11]
|
Bouadma L, et al. (2010) Use of Procalcitonin to Reduce Patients’ Exposure to Antibiotics in Intensive Care Units (PRORATA Trial): A Multicentre Randomised Controlled Trial. The Lancet, 375, 463-474. [Google Scholar] [CrossRef]
|
|
[12]
|
Schuetz, P., et al. (2011) Procalcitonin Algorithms for Antibiotic Therapy Decisions: A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms. Archives of Internal Medicine, 171, 1322-1331. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dellinger, R.P., et al. (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Critical Care Medicine, 41, 580-637. [Google Scholar] [CrossRef]
|
|
[14]
|
Maravic-Stojkovic, V., et al. (2011) Procalcitonin-Based Therapeutic Strategy to Reduce Antibiotic Use in Patients after Cardiac Surgery: A Randomized Controlled Trial. Srpski Arhiv Za Celokupno Lekarstvo, 139, 736-742. [Google Scholar] [CrossRef]
|
|
[15]
|
Hochreiter, M., et al. (2009) Procalcitonin to Guide Duration of Antibiotic Therapy in Intensive Care Patients: A Randomized Prospective Controlled Trial. Critical Care, 13, R83. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
de Jong, E., et al. (2016) Efficacy and Safety of Procalcitonin Guidance in Reducing the Duration of Antibiotic Treatment in Critically Ill Patients: A Randomised, Controlled, Open-Label Trial. The Lancet Infectious Diseases, 16, 819-827. [Google Scholar] [CrossRef]
|